Sitemap
Pages
News
- Arsenal Medical Appoints Ray Baker, M.D., to the Board of Directors
- NeoCast: An In Situ Curing, Shear-Responsive Biomaterial Designed for Durable Embolization of Microvasculature
- ResQFoam improves survival in a model of complex pelvic fracture and retroperitoneal exsanguination
- Arsenal Medical Announces Complete Enrollment of the Initial Cohort in the EMBO-02 Study
- ISC 2025: NeoCast EMBO-02 Poster
- Arsenal Medical Launches EMBO-02 Study for NeoCast™ to Assess Treatment of Chronic Subdural Hematoma
- Arsenal Medical Announces First-in-Human Results with NeoCast™
- Pre-Clinical Assessment of Distal Penetration, Radiopacity, and Biological Safety Response of NeoCast™
- Shear-Thinning Biomaterial for Embolic Applications
- Arsenal Medical Announces Treatment of First Patient with NeoCast™
- Arsenal Medical Presents Preclinical Data on Its Unique Embolic Biomaterial
- ResQFoam Study Seeks Feedback on Clinical Trial for Trauma Patients
- FDA approves clinical trial for potentially life-saving trauma foam
- This ResQFoam is Going to Save the Military Countless Lives
- This foam could save your life
- U.S. FDA grants Arsenal Medical investigational device exemption approval to conduct clinical ResQFoam study
- Pentagon hopes to use foam, injected through belly button, to save bleeding soldiers
- Arsenal Medical Secures Funding from U.S. Army to Advance ResQFoamTM Trauma Product through Regulatory Approval
- ResQFoam for the Treatment of Non-Compressible Hemorrhage on the Front Line
- Arsenal Medical and 480 Biomedical Raise $26.5 Million in Combined Funding for Development of Novel Products to Treat Vascular Disease and Abdominal Trauma
- Watertown Company Develops Life-Saving Trauma Foam
- Researchers Develop ‘Trauma Foam’ to Combat Internal Bleeding
- Arsenal Medical Announces Results of Novel Translational Research Study Determining Human Dose for its Trauma Foam Technology
- Expanding care - A new technique aims to prevent blood loss and save lives by using a rapidly expanding foam
- Watertown's Arsenal Medical Developing Foam to Buy Time for Wounded Soldiers
- Arsenal Medical’s Foam Technology for Battlefield Injuries Receives $15.5 Million Phase II DARPA Contract